Halozyme Therapeutics Inc
HALO77.810USD
+1.130+1.47%
收盘 09/19, 16:00（美东）报价延迟15分钟
9.15B总市值
16.42市盈率 TTM
关于 Halozyme Therapeutics Inc 公司
Halozyme Therapeutics, Inc. 是一家生物制药公司，致力于开发颠覆性解决方案，以改善新兴和成熟疗法的患者体验和疗效。该公司的 ENHANZE 药物输送技术采用专有酶 rHuPH20，其经过商业验证的解决方案用于促进注射药物和液体的皮下 (SC) 输送，重点是减轻患者的治疗负担。该公司还利用其先进的自动注射器技术为自己或与合作伙伴开发、制造和商业化药物-设备组合产品。该公司拥有两种商业专有产品 Hylenex 和 XYOSTED，与多家制药公司合作开发商业产品并正在进行产品开发计划。该公司营销和销售 Hylenex 重组体，这是 rHuPH20 的一种配方。该公司营销和销售其专有产品 XYOSTED，用于成年男性的睾酮替代疗法 (TRT) 的 SC 给药。
公司简介
公司代码HALO
公司名称Halozyme Therapeutics Inc
上市日期Jan 30, 2003
CEODr. Helen I. Torley
员工数量350
证券类型Ordinary Share
年结日Jan 30
公司地址12390 El Camino Real
城市SAN DIEGO
上市交易所NASDAQ Global Select Consolidated
国家United States of America
邮编92130
电话18587948889
网址https://www.halozyme.com/
公司代码HALO
上市日期Jan 30, 2003
CEODr. Helen I. Torley
公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Helen I. Torley
Dr. Helen I. Torley
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
733.72K
--
Mr. Matthew L. (Matt) Posard
Mr. Matthew L. (Matt) Posard
Independent Director
Independent Director
74.04K
+5.96%
Ms. Nicole Labrosse
Ms. Nicole Labrosse
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
24.31K
-23.81%
Dr. Mahesh Krishnan, M.D.
Dr. Mahesh Krishnan, M.D.
Independent Director
Independent Director
--
--
Ms. Moni Miyashita
Ms. Moni Miyashita
Independent Director
Independent Director
--
--
Mr. Jeffrey W. (Jeff) Henderson
Mr. Jeffrey W. (Jeff) Henderson
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Mark Snyder
Mr. Mark Snyder
Senior Vice President, Chief Compliance Officer, General Counsel, Secretary
Senior Vice President, Chief Compliance Officer, General Counsel, Secretary
--
--
Ms. Bernadette M. Connaughton
Ms. Bernadette M. Connaughton
Independent Director
Independent Director
--
--
Ms. Barbara Duncan
Ms. Barbara Duncan
Independent Director
Independent Director
--
--
Ms. Tram Bui
Ms. Tram Bui
Vice President - Investor Relations and Corporate Communications
Vice President - Investor Relations and Corporate Communications
--
--
名称
名称/职务
职务
持股
持股变动
Dr. Helen I. Torley
Dr. Helen I. Torley
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
733.72K
--
Mr. Matthew L. (Matt) Posard
Mr. Matthew L. (Matt) Posard
Independent Director
Independent Director
74.04K
+5.96%
Ms. Nicole Labrosse
Ms. Nicole Labrosse
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
24.31K
-23.81%
Dr. Mahesh Krishnan, M.D.
Dr. Mahesh Krishnan, M.D.
Independent Director
Independent Director
--
--
Ms. Moni Miyashita
Ms. Moni Miyashita
Independent Director
Independent Director
--
--
Mr. Jeffrey W. (Jeff) Henderson
Mr. Jeffrey W. (Jeff) Henderson
Independent Chairman of the Board
Independent Chairman of the Board
--
--
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Royalties
168.19M
63.50%
Sales of proprietary products
36.34M
13.72%
Sales of bulk rHuPH20
27.02M
10.20%
Sales-based milestones
15.00M
5.66%
Sales of device partnered products
14.68M
5.54%
其他
3.63M
1.37%
暂无数据
业务
地区
业务USD
名称
营收
占比
Royalties
168.19M
63.50%
Sales of proprietary products
36.34M
13.72%
Sales of bulk rHuPH20
27.02M
10.20%
Sales-based milestones
15.00M
5.66%
Sales of device partnered products
14.68M
5.54%
其他
3.63M
1.37%
股东统计
更新时间: 8月16日 周六
更新时间: 8月16日 周六
持股股东
股东类型
持股股东
持股股东
占比
The Vanguard Group, Inc.
10.45%
BlackRock Institutional Trust Company, N.A.
10.01%
State Street Global Advisors (US)
5.07%
Snyder Capital Management, L.P.
2.90%
Arrowstreet Capital, Limited Partnership
2.17%
其他
69.39%
持股股东
持股股东
占比
The Vanguard Group, Inc.
10.45%
BlackRock Institutional Trust Company, N.A.
10.01%
State Street Global Advisors (US)
5.07%
Snyder Capital Management, L.P.
2.90%
Arrowstreet Capital, Limited Partnership
2.17%
其他
69.39%
股东类型
持股股东
占比
Investment Advisor
54.81%
Investment Advisor/Hedge Fund
32.14%
Hedge Fund
5.05%
Research Firm
4.88%
Pension Fund
3.00%
Bank and Trust
1.58%
Individual Investor
1.16%
Sovereign Wealth Fund
0.89%
Venture Capital
0.20%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
1037
125.48M
107.21%
-10.05M
2025Q1
1043
127.91M
103.79%
-10.64M
2024Q4
999
127.73M
103.64%
-14.45M
2024Q3
953
129.39M
102.16%
-10.33M
2024Q2
905
126.24M
99.18%
-14.91M
2024Q1
870
127.71M
100.45%
-13.70M
2023Q4
850
128.82M
97.51%
-11.71M
2023Q3
836
127.73M
96.80%
-13.97M
2023Q2
838
128.24M
97.33%
-12.36M
2023Q1
833
129.53M
95.63%
-10.61M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
The Vanguard Group, Inc.
12.80M
10.39%
-451.45K
-3.41%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
14.99M
12.16%
-268.69K
-1.76%
Mar 31, 2025
State Street Global Advisors (US)
6.05M
4.91%
-1.13M
-15.75%
Mar 31, 2025
Snyder Capital Management, L.P.
3.67M
2.98%
-494.15K
-11.85%
Mar 31, 2025
AllianceBernstein L.P.
3.22M
2.61%
+146.68K
+4.78%
Mar 31, 2025
Geode Capital Management, L.L.C.
3.17M
2.57%
+105.17K
+3.43%
Mar 31, 2025
Macquarie Investment Management
2.67M
2.17%
-231.21K
-7.96%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
2.03M
1.65%
+95.60K
+4.94%
Mar 31, 2025
Congress Asset Management Company, LLP
2.13M
1.73%
+172.97K
+8.83%
Mar 31, 2025
查看更多
持股ETF
更新时间: 9月2日 周二
更新时间: 9月2日 周二
机构名称
占比
Future Fund Long/Short ETF
4.08%
First Trust NYSE Arca Biotechnology Index Fund
3.61%
Invesco Biotechnology & Genome ETF
3%
SPDR S&P Biotech ETF
2.69%
Congress SMid Growth ETF
2.49%
Janus Henderson Small Cap Growth Alpha ETF
2.43%
Janus Henderson Small/Mid Cap Growth Alpha ETF
2.32%
Virtus LifeSci Biotech Products ETF
2.12%
Invesco S&P MidCap 400 GARP ETF
2.11%
AAM Sawgrass US Small Cap Quality Growth ETF
2.03%
查看更多
Future Fund Long/Short ETF
占比4.08%
First Trust NYSE Arca Biotechnology Index Fund
占比3.61%
Invesco Biotechnology & Genome ETF
占比3%
SPDR S&P Biotech ETF
占比2.69%
Congress SMid Growth ETF
占比2.49%
Janus Henderson Small Cap Growth Alpha ETF
占比2.43%
Janus Henderson Small/Mid Cap Growth Alpha ETF
占比2.32%
Virtus LifeSci Biotech Products ETF
占比2.12%
Invesco S&P MidCap 400 GARP ETF
占比2.11%
AAM Sawgrass US Small Cap Quality Growth ETF
占比2.03%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
